animenews: FDA postpones panel meeting to review Sarepta's DMD drug

Affichage des articles dont le libellé est FDA postpones panel meeting to review Sarepta's DMD drug. Afficher tous les articles

mercredi 20 janvier 2016

FDA postpones panel meeting to review Sarepta's DMD drug

(Reuters) - The U.S. Food and Drug Administration postponed a meeting of its advisory panel to review Sarepta Therapeutics Inc's drug for a rare muscle wasting disorder due to inclement weather forecast for Washington DC.

http://ift.tt/1UcILGk

from Reuters: Health News
via animenewspro

animenews

تعديل

mercredi 20 janvier 2016

FDA postpones panel meeting to review Sarepta's DMD drug

التسميات

أرشيف المدونة الإلكترونية